• Signant Health brings its eConsent solution to China biospectrumasia
    September 16, 2019
    The investigator-initiated schizophrenia focus trial, which will be the first Chinese study using Signant's TrialConsent solution, will involve hundreds of patients from multiple sites.
PharmaSources Customer Service